Donate to PAPAA
All this information is available to you FREE. If you found it useful please show your appreciation. Thank you.
The PAPAA Forum: Psoriasis, Dr David Ashton, Nov 2020
Systemic drug therapy in the obese patient with psoriasis
- Author: Dr David Ashton
- Topic: Psoriasis
Should a patient’s Body Mass Index (BMI) influence the choice of a systemic drug in the treatment of psoriasis and psoriatic arthritis? A recent report suggests that the answer is ‘Yes’1.
There is a strong and consistent association between obesity and psoriasis; obese patients are more likely to develop psoriasis and its severity increases with …
